As of 2025-11-15, the Relative Valuation of Bolt Biotherapeutics Inc (BOLT) is (248.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.57 USD, the upside of Bolt Biotherapeutics Inc based on Relative Valuation is -5532.9%.
The range of the Relative Valuation is (151.08) - (319.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.7x - 12.1x | 9.4x |
| Forward P/E multiples | 5.7x - 12.2x | 9.4x |
| Fair Price | (151.08) - (319.07) | (248.28) |
| Upside | -3406.0% - -7081.8% | -5532.9% |
| Date | P/E |
| 2025-11-14 | -0.17 |
| 2025-11-13 | -0.18 |
| 2025-11-12 | -0.18 |
| 2025-11-11 | -0.18 |
| 2025-11-10 | -0.19 |
| 2025-11-07 | -0.17 |
| 2025-11-06 | -0.18 |
| 2025-11-05 | -0.18 |
| 2025-11-04 | -0.19 |
| 2025-11-03 | -0.21 |
| 2025-10-31 | -0.22 |
| 2025-10-30 | -0.22 |
| 2025-10-29 | -0.22 |
| 2025-10-28 | -0.22 |
| 2025-10-27 | -0.24 |
| 2025-10-24 | -0.23 |
| 2025-10-23 | -0.22 |
| 2025-10-22 | -0.21 |
| 2025-10-21 | -0.22 |
| 2025-10-20 | -0.22 |
| 2025-10-17 | -0.22 |
| 2025-10-16 | -0.22 |
| 2025-10-15 | -0.23 |
| 2025-10-14 | -0.22 |
| 2025-10-13 | -0.22 |
| 2025-10-10 | -0.22 |
| 2025-10-09 | -0.22 |
| 2025-10-08 | -0.24 |
| 2025-10-07 | -0.23 |
| 2025-10-06 | -0.20 |
| 2025-10-03 | -0.20 |
| 2025-10-02 | -0.19 |
| 2025-10-01 | -0.21 |
| 2025-09-30 | -0.20 |
| 2025-09-29 | -0.20 |
| 2025-09-26 | -0.21 |
| 2025-09-25 | -0.21 |
| 2025-09-24 | -0.22 |
| 2025-09-23 | -0.21 |
| 2025-09-22 | -0.20 |
| 2025-09-19 | -0.20 |
| 2025-09-18 | -0.20 |
| 2025-09-17 | -0.20 |
| 2025-09-16 | -0.19 |
| 2025-09-15 | -0.20 |
| 2025-09-12 | -0.20 |
| 2025-09-11 | -0.20 |
| 2025-09-10 | -0.20 |
| 2025-09-09 | -0.19 |
| 2025-09-08 | -0.19 |